COMMUNIQUÉS West-GlobeNewswire

DBV Technologies annonce l’exercice de la totalité de l’option de surallocation consentie dans le cadre de son offre globale d’actions ordinaires pouvant prendre la forme d’American Depositary Shares
05/04/2019
Montrouge, France, le 5 avril (07h30 CEST), 2019 DBV Technologies annonce l’exercice de la totalité de l’option de surallocation consentie dans le cadre de son offre globale d’actions ordinaires pouvant prendre la forme [...]
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
05/04/2019
Amsterdam, The Netherlands – 05 April 2019 Esperite N.V. (Euronext: ESP, “ Esperite ”) announces today a EUR 250,000 private placement of 25 convertible notes with a principal amount of EUR 10,000 each (the “ Notes ”), [...]
Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES
05/04/2019
PRESS RELEASE REGULATED INFORMATION 5 April 2019, 07:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 5 April 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Zealand Pharma announces Emmanuel Dulac as new CEO
05/04/2019
Company announcement – No. 11 / 2019 Zealand Pharma announces Emmanuel Dulac as new CEO Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel comes from a position as Chief [...]
AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia
05/04/2019
TOKYO, April 05, 2019 (GLOBE NEWSWIRE) -- AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for treating serious diseases, announced today that they have obtained conditional [...]
Profound Medical Announces Positive Topline Results from TACT Pivotal Clinical Trial of TULSA-PRO® in Patients with Prostate Cancer
05/04/2019
All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved TORONTO, April 04, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
04/04/2019
Company Release no. 07/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 04 April 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018
04/04/2019
COPENHAGEN, Denmark, April 04, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results [...]
Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04/04/2019
BOSTON, April 04, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) (the “Company”) a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies [...]
BeyondSpring to Present at the 18th Annual Needham Healthcare Conference
04/04/2019
NEW YORK, April 04, 2019 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, announced today that management will provide a [...]
Axovant Announces Plan to Effect Reverse Share Split
04/04/2019
- Closing of $40 million financing with participation from leading shareholders - - 1-for-8 reverse share split expected in May 2019 - BASEL, Switzerland, April 04, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. ( [...]
Vital Therapies, Inc. Announces Stockholder Approval of Business Combination with Immunic AG
04/04/2019
SAN DIEGO, April 04, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL) announced that its stockholders voted to approve the proposals required to complete the business combination with Immunic AG at a special [...]
Homology Medicines Presents Preclinical Data from PKU Gene Therapy Program Demonstrating Restored Metabolic Pathway and Increased Neurotransmitter Production
04/04/2019
Company Announced IND Clearance Today for Phase 1/2 Clinical Trial BEDFORD, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today preclinical [...]
Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results
04/04/2019
SOUTH SAN FRANCISCO, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, [...]
Novartis updates on the migraine collaboration with Amgen
04/04/2019
Basel, April 4, 2019 - Novartis announced today that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of termination of its [...]
IBRI issues its digital and print 2018 Annual Report, “Discovery With Purpose” Diabetes, biopharmaceutical research and health data analytics research expanded
04/04/2019
INDIANAPOLIS, April 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the release of its print and digital 2018 Annual Report. The report theme is “Discovery With Purpose,” [...]
Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing
04/04/2019
MIRAMAR, FL, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second quarter, filed on March [...]
Aleafia Health Launches Cannabis Education Platform FoliEdge Academy
04/04/2019
FoliEdge Academy Built with D2L, a World Leading Online Learning Company Insurance Technology Executive Rob Tyrie Named Head of FoliEdge Academy Interactive, Cloud-based Courses for Employers, Unions, Universities, [...]
IBT publishes annual report for 2018
04/04/2019
Today, Infant Bacterial Therapeutics AB (publ) publishes the Annual Report for the financial year 2018. The report is available on IBT’s website ibtherapeutics.com under the section “Investors & Media – Financial [...]

Pages